FDA Approved: SIRTURO — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved Janssen's supplemental application for SIRTURO (bedaquiline fumarate), updating the labeling to reflect the approved changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• SIRTURO (bedaquiline fumarate)

Snippet

SUPPL AP for SIRTURO (BEDAQUILINE FUMARATE)